相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR activation and interference screens decode stimulation responses in primary human T cells
Ralf Schmidt et al.
SCIENCE (2022)
Machine and deep learning approaches for cancer drug repurposing
Naiem T. Issa et al.
SEMINARS IN CANCER BIOLOGY (2021)
Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system
Tomasz Kostrzewski et al.
COMMUNICATIONS BIOLOGY (2021)
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
Yann Ayotte et al.
ACS CHEMICAL BIOLOGY (2021)
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
Anja Irmisch et al.
CANCER CELL (2021)
The Rise of Molecular Glues
Stuart L. Schreiber
CELL (2021)
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Srinivas Niranj Chandrasekaran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Plinio C. Casarotto et al.
CELL (2021)
Lacosamide Inhibition of NaV1.7 Channels Depends on its Interaction With the Voltage Sensor Domain and the Channel Pore
Julie I. R. Labau et al.
FRONTIERS IN PHARMACOLOGY (2021)
Top companies and drugs by sales in 2020
Lisa Urquhart
NATURE REVIEWS DRUG DISCOVERY (2021)
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension
Mingxia Gu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Organs-on-a-chip models for biological research
Gordana Vunjak-Novakovic et al.
CELL (2021)
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
E. Elizabeth Patton et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen E. Gitelman et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Thermal proteome profiling identifies the membrane- bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolin
Marjorie A. Carnero Corrales et al.
CELL CHEMICAL BIOLOGY (2021)
Small-molecule probe reveals a kinase cascade that links stress signaling to TCF/LEF and Wnt responsiveness
Jiongjia Cheng et al.
CELL CHEMICAL BIOLOGY (2021)
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoE
Uthpala Seneviratne et al.
CELL CHEMICAL BIOLOGY (2021)
High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need
Rebecca E. Hughes et al.
CELL CHEMICAL BIOLOGY (2021)
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Ye Yao et al.
CELL STEM CELL (2020)
Use of Zebrafish in Drug Discovery Toxicology
Steven Cassar et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
CRISPR: A Screener's Guide
Carlos le Sage et al.
SLAS DISCOVERY (2020)
Dual-target kinase drug design: Current strategies and future directions in cancer therapy
Dejuan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-b]pyridazines for the Treatment of Human African Trypanosomiasis
Westley F. Tear et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Rethinking drug design in the artificial intelligence era
Petra Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Immune-competent in vitro co-culture models as an approach for skin sensitisation assessment
Amelie Thelu et al.
TOXICOLOGY IN VITRO (2020)
Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ
Sungjin Ahn et al.
BIOMOLECULES (2020)
High throughput in vivo phenotypic screening for drug repurposing: Discovery of MLR-1023 a novel insulin sensitizer and novel Lyn kinase activator with clinical proof of concept
Christopher A. Lipinski et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
A Deep Learning Approach to Antibiotic Discovery (vol 180, pg 688.e1, 2020)
Jonathan M. Stokes et al.
CELL (2020)
DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials
Arash Keshavarzi Arshadi et al.
FRONTIERS IN PHARMACOLOGY (2020)
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
What Are the Odds of Finding a COVID-19 Drug from a Lab Repurposing Screen?
Aled Edwards
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Identification and Tracking of Antiviral Drug Combinations
Aleksandr Ianevski et al.
VIRUSES-BASEL (2020)
'IT WILL CHANGE EVERYTHING': DEEPMIND'S AI MAKES GIGANTIC LEAP IN SOLVING PROTEIN STRUCTURES
Ewen Callaway
NATURE (2020)
Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies
Fabien Vincent et al.
CELL CHEMICAL BIOLOGY (2020)
A Microphysiological System for Studying Nonalcoholic Steatohepatitis
Tomasz Kostrzewski et al.
HEPATOLOGY COMMUNICATIONS (2020)
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Sarina A. Piha-Paul et al.
JNCI CANCER SPECTRUM (2020)
Oral Therapies for Multiple Sclerosis
Simon Faissner et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Systems Pharmacology: Defining the Interactions of Drug Combinations
J. G. Coen van Hasselt et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline
Jens M. Kelm et al.
DRUG DISCOVERY TODAY (2019)
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs
Michael D. Shultz
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Accurate Prediction of Biological Assays with High-Throughput Microscopy Images and Convolutional Networks
Markus Hofmarcher et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip
Sasan Jalili-Firoozinezhad et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Developing zebrafish disease models for in vivo small molecule screens
Pui-Ying Lam et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Target 2035: probing the human proteome
Adrian J. Carter et al.
DRUG DISCOVERY TODAY (2019)
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
Nina Dedic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Safety screening in early drug discovery: An optimized assay panel
Stefanie Bendels et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology
Chenxiao Da et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Ann Lin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Structural basis of a small molecule targeting RNA for a specific splicing correction
Sebastien Campagne et al.
NATURE CHEMICAL BIOLOGY (2019)
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh et al.
NATURE MEDICINE (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Deep Learning for Deep Chemistry: Optimizing the Prediction of Chemical Patterns
Tania F. G. G. Cova et al.
FRONTIERS IN CHEMISTRY (2019)
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Hepatitis C - New drugs and treatment prospects
Marianna Zajac et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474
Zhen Huang et al.
ACS CHEMICAL BIOLOGY (2019)
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Garrett R. Ainslie et al.
LAB ON A CHIP (2019)
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets
Natalia J. Sumi et al.
CELL CHEMICAL BIOLOGY (2019)
The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery
Alexandra Friese et al.
CELL CHEMICAL BIOLOGY (2019)
Machine learning-powered antibiotics phenotypic drug discovery
Sannah Zoffmann et al.
SCIENTIFIC REPORTS (2019)
Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets
Prson Gautam et al.
CELL CHEMICAL BIOLOGY (2019)
Inhibition of hepatitis B virus gene expression: A step towards functional cure
Fabien Zoulim
JOURNAL OF HEPATOLOGY (2018)
Machine Learning Enables Live Label-Free Phenotypic Screening in Three Dimensions
Eoghan O'Duibhir et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2018)
Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective
Kenneth M. Comess et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Mariano J. Alvarez et al.
NATURE GENETICS (2018)
Glimmers in illuminating the druggable genome
Griffin Rodgers et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Concerns, challenges and promises of high-content analysis of 3D cellular models
Neil Carragher et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Principles for targeting RNA with drug-like small molecules
Katherine Deigan Warner et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Systematic exploration of cell morphological phenotypes associated with a transcriptomic query
Isar Nassiri et al.
NUCLEIC ACIDS RESEARCH (2018)
Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells
Adelina Orellana et al.
PLOS ONE (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
Jasper Edgar Neggers et al.
NATURE COMMUNICATIONS (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Laurent R. Chiarelli et al.
SCIENTIFIC REPORTS (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Lead-like Drugs: A Perspective
Brian Raymer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells
Ben M. Maoz et al.
NATURE BIOTECHNOLOGY (2018)
Mining Gene Expression Data for Drug Discovery
Melissa Pandika
ACS CENTRAL SCIENCE (2018)
The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care
John G. Clohessy et al.
FRONTIERS IN ONCOLOGY (2018)
A review on machine learning methods for in silico toxicity prediction
Gabriel Idakwo et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2018)
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)
Atwood K. Cheung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action
Xingchun Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery
Jaak Simm et al.
CELL CHEMICAL BIOLOGY (2018)
A novel orally available small molecule that inhibits hepatitis B virus expression
Henrik Mueller et al.
JOURNAL OF HEPATOLOGY (2018)
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
Susan H. Smith et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
Applications of chemogenomic library screening in drug discovery
Lyn H. Jones et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal et al.
SCIENCE (2017)
A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders
David Millrine et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
Manaswini Sivaramakrishnan et al.
NATURE COMMUNICATIONS (2017)
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
Nathanael G. Lintner et al.
PLOS BIOLOGY (2017)
Systematic morphological profiling of human gene and allele function via Cell Painting
Mohammad Hossein Rohban et al.
ELIFE (2017)
Molecular Connectivity Predefines Polypharmacology: Aliphatic Rings, Chirality, and sp3 Centers Enhance Target Selectivity
Stefania Monteleone et al.
FRONTIERS IN PHARMACOLOGY (2017)
Classics in Chemical Neuroscience: Memantine
Shahrina Alam et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Animal Models in Translational Research: Rosetta Stone or Stumbling Block?
Jessica A. Bolker
BIOESSAYS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
Falgun Shah et al.
CELL CHEMICAL BIOLOGY (2017)
How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice
Dorothea Haasen et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery
Faye Marie Drawnel et al.
CELL CHEMICAL BIOLOGY (2017)
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Christopher G. Parker et al.
CELL (2017)
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics
Luc de Waal et al.
NATURE CHEMICAL BIOLOGY (2016)
High-throughput Phenotyping of Lung Cancer Somatic Mutations
Alice H. Berger et al.
CANCER CELL (2016)
Applications in image-based profiling of perturbations
Juan C. Caicedo et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
Danming Zhu et al.
JOURNAL OF IMMUNOLOGY (2016)
The molecular mechanism of thalidomide analogs in hematologic malignancies
Stefanie Lindner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
Channing Yu et al.
NATURE BIOTECHNOLOGY (2016)
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
Richard M. Deans et al.
NATURE CHEMICAL BIOLOGY (2016)
Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes
Mark-Anthony Bray et al.
NATURE PROTOCOLS (2016)
Screening out irrelevant cell-based models of disease
Peter Horvath et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
Liming Shao et al.
MEDCHEMCOMM (2016)
Phenotypic Assessment and the Discovery of Topiramate
Bruce E. Maryanoff
ACS MEDICINAL CHEMISTRY LETTERS (2016)
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
Jack W. Scannell et al.
PLOS ONE (2016)
The Emerging Role of RNA as a Therapeutic Target for Small Molecules
Colleen M. Connelly et al.
CELL CHEMICAL BIOLOGY (2016)
A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation
Donna N. Petersen et al.
CELL CHEMICAL BIOLOGY (2016)
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
Hassan Al-Ali et al.
ACS CHEMICAL BIOLOGY (2015)
The Clinical Discovery of Imipramine
Walter A. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Engineered In Vitro Disease Models
Kambez H. Benam et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
Giorgia Mori et al.
CHEMISTRY & BIOLOGY (2015)
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
Michael A. Rogawski et al.
EPILEPSY RESEARCH (2015)
High-throughput analysis of behavior for drug discovery
Vadim Alexandrov et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain
John S. Tokarski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmics
Radda Rusinova et al.
JOURNAL OF GENERAL PHYSIOLOGY (2015)
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
James Palacino et al.
NATURE CHEMICAL BIOLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
Mouse hospital and co-clinical trial project-from bench to bedside
John G. Clohessy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Developing predictive assays: The phenotypic screening rule of 3
Fabien Vincent et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Strategies for improving the physiological relevance of human engineered tissues
Rosalyn D. Abbott et al.
TRENDS IN BIOTECHNOLOGY (2015)
Target (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry
Ramzi F. Sweis
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2
Takayuki Yoshida et al.
Oncotarget (2015)
Consideration of the cellular microenvironment: Physiologically relevant co-culture systems in drug discovery
Ellen L. Berg et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect
Makonen Belema et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
Nicole C. Kleinstreuer et al.
NATURE BIOTECHNOLOGY (2014)
The discovery of first-in-class drugs: origins and evolution
Joerg Eder et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Phenotypic screening in cancer drug discovery - past, present and future
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Nikolai A. Naryshkin et al.
SCIENCE (2014)
Anticancer Flavonoids Are Mouse-Selective STING Agonists
Sujeong Kim et al.
ACS CHEMICAL BIOLOGY (2013)
Chemical Interrogation of the Neuronal Kinome Using a Primary Cell-Based Screening Assay
Hassan Al-Ali et al.
ACS CHEMICAL BIOLOGY (2013)
Next-Generation NAMPT Inhibitors Identified by Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens
Christina J. Matheny et al.
CHEMISTRY & BIOLOGY (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Target identification and mechanism of action in chemical biology and drug discovery
Monica Schenone et al.
NATURE CHEMICAL BIOLOGY (2013)
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Multiplex Cytological Profiling Assay to Measure Diverse Cellular States
Sigrun M. Gustafsdottir et al.
PLOS ONE (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research
C. R. Hooijmans et al.
PLOS MEDICINE (2013)
Polypharmacology: drug discovery for the future
A. Srinivas Reddy et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
Michael P. Boyle et al.
LANCET RESPIRATORY MEDICINE (2013)
The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today?
Jean-Pierre Maffrand
COMPTES RENDUS CHIMIE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Minoxidil Use in Dermatology, Side Effects and Recent Patents
Alfredo Rossi et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2012)
The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
Alexander R. Ochman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase In Vitro That Improves Glucose Tolerance In Vivo
Michael S. Saporito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Uses of the in vitro endothelial-fibroblast organotypic co-culture assay in angiogenesis research
Clare Hetheridge et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effects
Jorn Loetsch et al.
DRUG DISCOVERY TODAY (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Hepatitis B therapy
Hellan Kwon et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms
Steven L. Roberds et al.
FRONTIERS IN NEUROSCIENCE (2011)
Micropatterning as a tool to decipher cell morphogenesis and functions
Manuel Thery
JOURNAL OF CELL SCIENCE (2010)
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
Richard Morphy
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm et al.
JOURNAL OF VIROLOGY (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
The topology of drug-target interaction networks: implicit dependence on drug properties and target families
Jordi Mestres et al.
MOLECULAR BIOSYSTEMS (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identifying the proteins to which small-molecule probes and drugs bind in cells
Shao-En Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Target deconvolution strategies in drug discovery
Georg C. Terstappen et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
P. K. Gillman
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Hossein A. Ghofrani et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry
T Kosaka et al.
ANALYTICAL CHEMISTRY (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models
EJ Kunkel et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2004)
Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations
S Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The discovery of ezetimibe: A view from outside the receptor
JW Clader
JOURNAL OF MEDICINAL CHEMISTRY (2004)
An integrative biology approach for analysis of drug action in models of human vascular inflammation
EJ Kunkel et al.
FASEB JOURNAL (2004)
Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
R Capdeville et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
AL Wijayaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
P2Y12, a new platelet ADP receptor, target of clopidogrel
P Savi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification and biological activity of the active metabolite of clopidogrel
P Savi et al.
THROMBOSIS AND HAEMOSTASIS (2000)
分享论文
